Harmony Biosciences Holdings HRMY
NASDAQ HRMY
$38.88 -0.41 (-1.04%)
As of: Sep 30, 2026 · 10:23 AM EDT

Harmony Biosciences Holdings (HRMY) EBIT (2019 - 2026)

Updated

Harmony Biosciences Holdings' EBIT came in at $89.32 million for Q2 2026, up 85.4% from $48.18 million a year earlier and up 139.5% from the prior quarter.

Analysis

Harmony Biosciences Holdings (HRMY) EBIT (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Harmony Biosciences Holdings reported EBIT of $230.65 million, up 4.0% year-over-year; for FY2025, it was $208.47 million, up 9.2% from FY2024.

  • EBIT carries a five-year compound annual growth rate of 65.1% (FY2020 to FY2025).
  • Going back by year, EBIT was $190.83 million in FY2024 (-0.6%), $192.03 million in FY2023 (+59.8%), $120.19 million in FY2022 (+37.3%) and $87.53 million in FY2021 (+415.3%).
  • The Q2 2026 figure represents the highest quarterly EBIT in data going back to Q3 2019.
  • Year-over-year, EBIT increased in five of the last eight quarters, with growth averaging 24.4%.
  • The fastest year-over-year change in EBIT over five years came in Q3 2023 (growth of 442.0%), and the weakest in Q2 2024 (a decline of 54.5%).
  • Business Quant data shows HRMY's EBIT at $37.29 million (Q1 2026), $38.56 million (Q4 2025) and $65.49 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 7.14 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 6.43 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 3.16 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -10.39 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.25 Bn
10 Harmony Biosciences Holdings 2.33 Bn -431.22 Mn 198.08 Mn 89.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 89.32 Mn
Mar 31, 2026 37.29 Mn
Dec 31, 2025 38.56 Mn
Sep 30, 2025 65.49 Mn
Jun 30, 2025 48.18 Mn
Mar 31, 2025 56.25 Mn
Dec 31, 2024 55.73 Mn
Sep 30, 2024 61.71 Mn
Jun 30, 2024 21.36 Mn
Mar 31, 2024 52.03 Mn
Dec 31, 2023 40.20 Mn
Sep 30, 2023 64.51 Mn
Jun 30, 2023 46.90 Mn
Mar 31, 2023 40.42 Mn
Dec 31, 2022 47.61 Mn
Sep 30, 2022 11.90 Mn
Jun 30, 2022 33.12 Mn
Mar 31, 2022 27.56 Mn
Dec 31, 2021 28.63 Mn
Sep 30, 2021 21.05 Mn
API Access

Harmony Biosciences Holdings EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=HRMY&period=max&api_key=YOUR_API_KEY